SAROJA — Saroja Pharma Industries India Share Price
Last trade - 00:00- IN₹188.96m
- IN₹290.85m
- IN₹501.93m
- 16
- 63
- 21
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.71 | ||
| Price to Tang. Book | 3.71 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.38 | ||
| EV to EBITDA | 8.24 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 43.78% | ||
| Return on Equity | 20.85% | ||
| Operating Margin | 6.9% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 170.8 | 366.62 | 556.33 | 501.93 | n/a | n/a | 43.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +354.41 | +55.9 | -6.97 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Saroja Pharma Industries India Limited is an India-based pharmaceutical and healthcare company. The Company is focused on trading in pharma active pharmaceuticals ingredients (API), pharma intermediates, chemicals, solvents used for pharmaceutical products human and veterinary medicine. It is also engaged in specialty chemical imports and exports as well as supplying the same to the users. Its specialty chemicals and intermediates have wide application in sectors like pharma, agro and chemicals for humans and veterinarians. The Company deals in three types of product category, such as Chemical, Pharma Intermediary, and API. Its chemical products include Liquid Bromine, Ethyl Acetate, Thionyl Chloride, Para Nitro Phenol, Toluene N.G, And Benzyl Chloride. The Company’s API products include Bromhexine HCL BP Grade, Triclabendazole, Fenbendazole BP Vet, Nitroxynil BP Vet, Oxfendazole BP Vet, Albendazole USP, Rafoxanide BP Vet, and Febantel EP, among others.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- January 1st, 1970
- Incorporated
- January 14th, 2019
- Public Since
- September 13th, 2023
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 4,020,486
- Address
- MUMBAI, 400080
- Web
- https://www.sarojapharma.com/
- Phone
- +91 2220810011
- Auditors
- Pravin Chandak & Associates
Similar to SAROJA
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 19:19 UTC, shares in Saroja Pharma Industries India are trading at IN₹47.00. This share price information is delayed by 15 minutes.
Shares in Saroja Pharma Industries India last closed at IN₹47.00 and the price had moved by over the past 365 days. In terms of relative price strength the Saroja Pharma Industries India share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Saroja Pharma Industries India does not currently pay a dividend.
Saroja Pharma Industries India does not currently pay a dividend.
Saroja Pharma Industries India does not currently pay a dividend.
To buy shares in Saroja Pharma Industries India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹47.00, shares in Saroja Pharma Industries India had a market capitalisation of IN₹188.96m.
Here are the trading details for Saroja Pharma Industries India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SAROJA
Based on an overall assessment of its quality, value and momentum Saroja Pharma Industries India is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Saroja Pharma Industries India. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -31.34%.
As of the last closing price of IN₹47.00, shares in Saroja Pharma Industries India were trading -11.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Saroja Pharma Industries India PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹47.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Saroja Pharma Industries India's directors